Key Takeaways TEM's updated Pixel platform gained FDA clearance for advanced cardiac MR image analysis.The update enables the generation of T1 and T2 inline maps for tissue characterization. Tempus expanded imaging capabilities with its 2022 acquisition of Arterys. Tempus AI (TEM) has developed and deployed a suite of advanced algorithms across radiology, helping physicians deliver more precise and personalized care. Its strategic acquisitions have further strengthened its footprint in these fields. As per ...